FDA authorizes robotic blood draw device: ‘First-of-its-kind’

A robotic device has been authorized by the FDA to autonomously draw blood from patients. This device is considered first-of-its-kind.

Further information is available on how the device works.

The FDA authorization allows the device to be used, but details of its operation are not provided here, and can be found through additional sources.